Elevation Oncology Inc (NASDAQ:ELEV) Stock Continues to Trend Lower: Fell 10% Last Week
Elevation Oncology Inc (NASDAQ:ELEV) is currently involved in developing precision medicines that can help in treating patients suffering from genomically defined cancers. Market Reaction On Friday, ELEV stock moved down 7% to $7.69 with more than 8.66k shares, compared to… Continue Reading